Market access planning, assessment & tracking
Evidence planning, payer logic, and tracking approaches grounded in UK system reality — connecting data, narrative, and field execution.
Showroom
Related live demos
Open working examples in context — supplementary to a conversation, not a substitute for scoping your own datasets and governance.
- Governed micro-learning demo — interactive healthcare education design
Governed micro-learning demo
This showroom example recreates an AATD micro-learning module from the Alpha-1 Companion source app as a web-based education surface, including module cards, key points, knowledge checks, explanation feedback, and completion summary.
- Embedded analytics — illustrated with obesity in England
Embedded analytics showcase
Eye4Health delivers interrogable analytics inside a governed, on-brand web experience — so medical, market access, and brand teams share one evidence story in workshops and planning. Below is a live illustration on open public-health data; commissioned work uses your sources, controls, and narrative.
The problem we see
Access strategies often read well on paper but fail when confronted with local variation, evidence gaps, and the pace of NHS change.
Outcome we work towards: A practical access plan: what to prove, where it matters, how to monitor it, and how to adapt as decisions land.
Business questions
- What evidence will stakeholders accept — and what will not move the needle?
- Where is local variation likely to dominate national assumptions?
- How do we track progress without drowning in metrics nobody owns?
What Eye4Health delivers
- Evidence and narrative maps aligned to payer and pathway stakeholders
- Localisation frameworks that are honest about data limits
- Tracking dashboards designed for decisions — not for chart volume
Data and methods
- UK pathway and system datasets where relevant, plus structured qualitative inputs from field and medical
- Clear distinction between “public evidence” and “internal judgement calls”
- Iteration cadence that matches NHS decision timelines — not quarterly theatre
Who this is for
- Market access directors and managers
- Medical affairs colleagues shaping evidence generation
- Brand teams translating access constraints into prioritisation
Example outcome (anonymised)
An anonymised engagement reframed tracking around a handful of decision-ready indicators tied to named stakeholder types — reducing reporting load while improving actionability.
Related insights
Next step
If this matches a live decision on your side, a short working session usually clarifies scope fast — without a generic “sales deck” detour.